Patents by Inventor Marcus Larsson

Marcus Larsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240165311
    Abstract: The present invention relates to the field of stem cells and their use in processing ex vivo samples (e.g. blood samples). More specifically, the present invention relates to the use of mesenchymal stem cells in ECMO.
    Type: Application
    Filed: March 18, 2022
    Publication date: May 23, 2024
    Inventors: Marcus Larsson, Sandra Lindstedt Ingemansson
  • Patent number: 11981243
    Abstract: The present disclosure relates to a vehicle (100) comprising at least a towing vehicle (102), the towing vehicle comprising steerable wheels and is arranged to convey the vehicle in at least a major longitudinal forward direction (104) of the vehicle (100), wherein the vehicle further comprises a load handling arrangement (200) arranged to support transportation of material to or from the vehicle (100), the load handling arrangement (200) being configured to assume a material handling mode in which the load handling arrangement (200) is arranged to support transportation of the material between the vehicle (100) and a stationary ground portion (106) in the vicinity of the vehicle (100), wherein the load handling arrangement (200) extends substantially in the major longitudinal forward direction (104) of the vehicle over at least a portion of the towing vehicle (102) when assuming the material handling mode.
    Type: Grant
    Filed: February 22, 2019
    Date of Patent: May 14, 2024
    Assignee: Volvo Truck Corporation
    Inventors: Christina Hernvall, Lars Johansson, Mikael Lennartsson, Marcus Fasth, Bo Larsson
  • Publication number: 20230380693
    Abstract: A device, system and method for measuring free gas in a cavity of a subject. The device, system and method include a light source for emitting light with a wavelength associated with an absorption band of the free gas, an optical fibre connected to the light source and adapted to be inserted using an introducing member for internal illumination, and a detector adapted to be positioned on a skin surface for detecting light transmitted through the tissue. The device, system and method further includes a control unit for evaluating the detected transmitted light for determining the free gas, or a distribution of the free gas, or concentration of the free gas.
    Type: Application
    Filed: July 21, 2023
    Publication date: November 30, 2023
    Inventors: Sune SVANBERG, Emilie KRITE SVANBERG, Marcus LARSSON
  • Patent number: 11744467
    Abstract: A device, system and method for measuring free gas in a cavity of a subject. The device, system and method include a light source for emitting light with a wavelength associated with an absorption band of the free gas, an optical fibre connected to the light source and adapted to be inserted using an introducing member for internal illumination, and a detector adapted to be positioned on a skin surface for detecting light transmitted through the tissue. The device, system and method further includes a control unit for evaluating the detected transmitted light for determining the free gas, or a distribution of the free gas, or concentration of the free gas.
    Type: Grant
    Filed: August 17, 2016
    Date of Patent: September 5, 2023
    Assignee: NEOLA MEDICAL AB
    Inventors: Sune Svanberg, Emilie Krite Svanberg, Marcus Larsson
  • Publication number: 20230000922
    Abstract: Methods for purifying, culturing and selecting mesenchymal stem cell (MSC) subpopulations with neonatal quality and adult tissue specificity that are for use in production of advanced therapeutic medicinal products.
    Type: Application
    Filed: September 13, 2022
    Publication date: January 5, 2023
    Inventors: Jan TALTS, Niels-Bjarne WOODS, Kåre ENGKILDE, Marcus LARSSON
  • Publication number: 20220372444
    Abstract: Methods for purifying, culturing and selecting mesenchymal stem cell (MSC) subpopulations with neonatal quality and adult tissue specificity that are for use in production of advanced therapeutic medicinal products.
    Type: Application
    Filed: October 16, 2020
    Publication date: November 24, 2022
    Inventors: Jan Talts, Niels-Bjarne Woods, Kåre Engkilde, Marcus Larsson
  • Patent number: 11446334
    Abstract: Methods for purifying, culturing and selecting mesenchymal stem cell (MSC) subpopulations with neonatal quality and adult tissue specificity are for in production of advanced therapeutic medicinal products. In certain examples, term amniotic fluid derived cells having characteristics of lung cells can be isolated. In some the term amniotic fluid derived cells having characteristics of lung cells can be used in the treatment of acute and chronic respiratory diseases.
    Type: Grant
    Filed: December 30, 2021
    Date of Patent: September 20, 2022
    Assignee: AMNIOTICS AB
    Inventors: Jan Talts, Niels-Bjarne Woods, Kare Engkilde, Marcus Larsson
  • Publication number: 20220202311
    Abstract: A device, system and method for monitoring a pulmonary system of a subject. An optical member for emitting a light signal through a cavity of the pulmonary system of the subject. The optical member and a detector unit are configured to be positioned so that the light signal detected that has ebb transmitted from the optical member through the cavity. A control unit is configured for evaluating the detected light signal for determining a physiological status of said pulmonary system of the subject.
    Type: Application
    Filed: April 23, 2020
    Publication date: June 30, 2022
    Inventors: Vineta Fellman, Marcus Larsson, Emilie Krite Svanberg, Jim Larsson, Dennis Leander, Sara Bergsten, Märta Lewander Xu
  • Publication number: 20220118023
    Abstract: Methods for purifying, culturing and selecting mesenchymal stem cell (MSC) subpopulations with neonatal quality and adult tissue specificity are for in production of advanced therapeutic medicinal products. In certain examples, term amniotic fluid derived cells having characteristics of lung cells can be isolated. In some the term amniotic fluid derived cells having characteristics of lung cells can be used in the treatment of acute and chronic respiratory diseases.
    Type: Application
    Filed: December 30, 2021
    Publication date: April 21, 2022
    Inventors: Jan Talts, Nils-Bjarne Woods, Kare Engkilde, Marcus Larsson
  • Publication number: 20180235475
    Abstract: A device, system and method for measuring free gas in a cavity of a subject. The device, system and method include a light source for emitting light with a wavelength associated with an absorption band of the free gas, an optical fibre connected to the light source and adapted to be inserted using an introducing member for internal illumination, and a detector adapted to be positioned on a skin surface for detecting light transmitted through the tissue. The device, system and method further includes a control unit for evaluating the detected transmitted light for determining the free gas, or a distribution of the free gas, or concentration of the free gas.
    Type: Application
    Filed: August 17, 2016
    Publication date: August 23, 2018
    Inventors: Sune SVANBERG, Emilie KRITE SVANBERG, Marcus LARSSON
  • Patent number: 6770619
    Abstract: Lung surfactant compositions are provided which can form a swelling phase when dispersed in a medium containing electrolytes. Hereby, a more active spreading of the lung surfactant into the alveoli can be obtained after administration to the lungs. Further provided are a pharmaceutical composition and a pharmaceutical kit comprising a lung surfactant composition as well as to a method for the treatment, prevention and/or diagnosis of respiratory distress syndrome or other pulmonary diseases that are associated with a deficiency of a lung surfactant.
    Type: Grant
    Filed: August 31, 2001
    Date of Patent: August 3, 2004
    Inventors: Marcus Larsson, Kåre Larsson, Per Wollmer, Burkhard Lachmann, Johannes Jacobus Haitsma
  • Publication number: 20020072540
    Abstract: Lung surfactant compositions are provided which can form a swelling phase when dispersed in a medium containing electrolytes. Hereby, a more active spreading of the lung surfactant into the alveoli can be obtained after administration to the lungs. Further provided are a pharmaceutical composition and a pharmaceutical kit comprising a lung surfactant composition as well as to a method for the treatment, prevention and/or diagnosis of respiratory distress syndrome or other pulmonary diseases that are associated with a deficiency of a lung surfactant.
    Type: Application
    Filed: August 31, 2001
    Publication date: June 13, 2002
    Inventors: Marcus Larsson, Kare Larsson, Per Wollmer, Burkhard Lachmann, Johannes Jacobus Haitsma